Stanley T. Crooke

2020

In 2020, Stanley T. Crooke earned a total compensation of $9.5M as Executive Chairman at Ionis Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Bonus$587,665
Option Awards$4,267,239
Salary$683,630
Stock Awards$3,908,663
Other$39,332
Total$9,486,529

Crooke received $4.3M in option awards, accounting for 45% of the total pay in 2020.

Crooke also received $587.7K in bonus, $683.6K in salary, $3.9M in stock awards and $39.3K in other compensation.

Rankings

In 2020, Stanley T. Crooke's compensation ranked 895th out of 13,090 executives tracked by ExecPay. In other words, Crooke earned more than 93.2% of executives.

ClassificationRankingPercentile
All
895
out of 13,090
93rd
Division
Manufacturing
315
out of 5,617
94th
Major group
Chemicals And Allied Products
101
out of 2,248
96th
Industry group
Drugs
88
out of 1,948
96th
Industry
Pharmaceutical Preparations
68
out of 1,453
95th

Pay ratio

Stanley T. Crooke's Pay$9,486,529
Median Employee's Pay$352,641
Pay Ratio

27

to 1

In 2020, the annual total compensation of Stanley T. Crooke was $9,486,529.

The annual total compensation of the median employee at Ionis Pharmaceuticals was $352,641.

The ratio of Stanley T. Crooke's pay to the pay of median employee was therefore 27 to one.

Source: SEC filing on April 23, 2021.

Crooke's colleagues

We found four more compensation records of executives who worked with Stanley T. Crooke at Ionis Pharmaceuticals in 2020.

2020

Brett Monia

Ionis Pharmaceuticals

Chief Executive Officer

2020

Elizabeth Hougen

Ionis Pharmaceuticals

Chief Financial Officer

2020

Richard Geary

Ionis Pharmaceuticals

Executive Vice President, Chief Development Officer

2020

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

News

You may also like